Monday, January 21, 2019

Welcome to Drug Safety News. It's our goal to provide you current news and analysis regarding potentially dangerous medications and medical devices, and to highlight other issues of concern in the healthcare industry.

Just because a prescription drug or medical device is discussed below does not mean it's causing you harm. It simply means that safety issues have been raised. You should not stop using your medication or device simply because it's written about. Instead, you should click on the story, and become informed of the potential issues. If you have concerns after reading the information, then you should consult your physician, and determine the proper medical course for you.

Taking Anxiety Meds? Beware of Proton Pump Inhibitors Such As Nexium and Prilosec

Some of the most frequently prescribed medications in the U.S. are anxiety drugs. Also included on the list of common prescriptions: proton pump inhibitors, such as Nexium and Prilosec.Proton pump inhibitors (PPIs) have been associated with several severe, even life-threatening side effects when used frequently over...

Another Class of Diabetic Drugs to Beware of — Gliptins

One class of potentially dangerous diabetic prescriptions, SGLT-2 inhibitors, have been getting a great deal of attention these days. Meanwhile, a group of medications as gliptins have been flying under the radar. However, the risks associated with some drugs in this class are serious enough that medical experts recommend taking them off the market altogether....

Hundreds of Different Prescription Drugs Linked to Depression

This past year a team of researchers from the University of Illinois and Columbia University in New York published a study that found a strong correlation between depression and prescription drugs. Appearing in the June issue of the Journal of the American Medical Association, it has only now received notice in...

Proton Pump Inhibitors Possibly Linked to Elevated Stomach Cancer Risk

A study published in the journal Gut has found an association between the long-term use of proton pump inhibitors (PPIs) and a dramatically increased risk of developing stomach cancer. Surprisingly, this study was published over a year ago – and yet few sources outside of major medical publications have reported on...

Defective Medical Devices Made in the U.S. are Injuring Patients Overseas

There was a time when a label that stated “Made in the USA” was an assurance of quality, reliability,...

Drug Companies Lobbying To Raise Drug Prices For Senior Citizens

Major pharmaceutical companies just can’t seem to get enough cash, and they are now lobbying the federal government to...

FDA Approves New Indication for Xarelto

New Jersey-based drugmaker Johnson & Johnson (JNJ) and its partner, Bayer AG, received approval for a new indication for...

As the Nation Struggles With an Addiction Epidemic, the FDA Approves a New Opioid-Based Pain Medication

Just before the weekend, the U.S. Food and Drug Administration gave its approval for a new, powerful and fast-acting...

Medical Cannabis Goes Mainstream as the FDA Approves the First Marijuana-Based Prescription Drug

Parents with children suffering from treatment-resistant epilepsy got a major reason for hope this...

Proposed Oregon Law Would Ban Medicaid Coverage of Opioids After One Year of Use

In Oregon, usually one of the more progressive states in terms of social policy, lawmakers...

Promising New Treatments for Alzheimer’s Disease on the Horizon

In recent months, a line of research focusing on specific amino acid chains from a...

Oxycontin Makers Will Not Market To Doctors Anymore

The maker of Oxycontin has said that they'll no longer market their opioids directly...

Can Exercise Improve Cognitive Function in Alzheimer’s Patients?

Over the past several years, there have been numerous studies on physical activity and...

Prominent Medical Researcher Falsified Data on Stem Cell Therapy

In 2001, Dr. Piero Anversa, a prominent and well-respected scientist specializing in regenerative medicine,...

Abilify MyCite Vehicle Comes Under Fire Over Privacy Concerns

Almost one year ago, the FDA gave the green light to a “digital pill”...

Xarelto Fails to Prevent Clotting in Recent Trial

Johnson & Johnson’s and Bayer's recent attempt to expand the market for its controversial...

Taxotere Cases Moving Forward in New Jersey This Week

A total of 353 Taxotere lawsuits that were consolidated into multi-county litigation in New...

Proton Pump Inhibitors – Causing the Same Problem They Were Designed to Prevent (and More)

A study that came out in April has added to the long list of...